Diff Profiles › MTBLS1223_0001_00000001

Wild_Type_Control_vs_Treatment

Homo sapiens_Fibroblast_Drug Vehicle_HT01 wild type vs Homo sapiens_Fibroblast_Nicotinamide Riboside_HT01 wild type

p-value ≤ 0.05 1 significant 2025-09-26 00:00:00 Study: MTBLS1223
4 Total Features
1 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS1223_0001_00000001
Linked study
MTBLS1223 — NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome (Intracellular UPLC-MS assay)
Comparison
Homo sapiens_Fibroblast_Drug Vehicle_HT01 wild type vs Homo sapiens_Fibroblast_Nicotinamide Riboside_HT01 wild type
Group A
Wild type fibroblasts treated with drug vehicle.. Provides baseline for comparison with treated wild type samples.
Group B
Wild type fibroblasts treated with Nicotinamide Riboside.. Evaluates the effect of Nicotinamide Riboside on wild type fibroblasts.
Total features tested
4
Significant features
1
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
SENPVEZBRZQVST-HISDBWNOSA-O Deamido-NAD+ down 1e-06 0.00347